Researchers at UT Southwestern Medical Center have developed a CRISPR technique to efficiently correct the function of heart cells in patients with Duchenne muscular dystrophy (DMD). It involves making a single cut at strategic points along patient's DNA, with the team claiming their new approach has the potential to correct most of the 3,000 mutations that cause DMD.
.. Continue Reading New CRISPR method strategically targets gene mutations to correct DMD heart defectCategory: Medical
Tags: Related Articles:
- Gene therapy reverses muscular dystrophy symptoms in dogs
- New gene editing method corrects muscular dystrophy in mice
- CRISPR breakthrough treats diseases like diabetes without cutting DNA
- A-Gear exoskeletons keep users' arms useful
- New combination of drugs slows heart decline in muscular dystrophy patients
- Telomere-lengthening procedure turns clock back years in human cells
from New Atlas http://ift.tt/2EN76ll
No comments:
Post a Comment